Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
Medtronic
McKinsey
Express Scripts

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Bausch And Lomb Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Bausch And Lomb
International Patents:185
US Patents:23
Tradenames:66
Ingredients:53
NDAs:77

Drugs and US Patents for Bausch And Lomb

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 064047-001 Jan 31, 1996 AT RX No Yes ⤷  Try it Free ⤷  Try it Free
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes 7,629,345 ⤷  Try it Free Y ⤷  Try it Free
Bausch And Lomb SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 074449-001 Dec 29, 1995 RX No Yes ⤷  Try it Free ⤷  Try it Free
Bausch And Lomb PENTOLAIR cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 040075-001 Apr 29, 1994 AT RX No No ⤷  Try it Free ⤷  Try it Free
Bausch And Lomb TROPICAMIDE tropicamide SOLUTION/DROPS;OPHTHALMIC 040064-001 Jul 27, 1994 AT RX No No ⤷  Try it Free ⤷  Try it Free
Bausch And Lomb ALAWAY ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 021996-002 Feb 11, 2015 OTC Yes No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Bausch And Lomb

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb Inc LOTEMAX loteprednol etabonate GEL;OPHTHALMIC 202872-001 Sep 28, 2012 5,800,807 ⤷  Try it Free
Bausch And Lomb ALREX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020803-001 Mar 9, 1998 5,540,930*PED ⤷  Try it Free
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 6,699,492 ⤷  Try it Free
Bausch And Lomb MIOCHOL-E acetylcholine chloride FOR SOLUTION;OPHTHALMIC 020213-001 Sep 22, 1993 6,261,546 ⤷  Try it Free
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 4,996,335*PED ⤷  Try it Free
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 6,685,958 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ophthalmic Solution 0.5% ➤ Subscribe 2012-10-19
➤ Subscribe Ophthalmic Solution 1.5% ➤ Subscribe 2013-09-09
➤ Subscribe Ophthalmic Solution 0.07% ➤ Subscribe 2013-07-26

Supplementary Protection Certificates for Bausch And Lomb Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0509752 C990041 Netherlands ⤷  Try it Free PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306
3461484 132021000000068 Italy ⤷  Try it Free PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108
1586316 C 2011 004 Romania ⤷  Try it Free PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518
1280520 300722 Netherlands ⤷  Try it Free PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
3461484 301101 Netherlands ⤷  Try it Free PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108
0364417 C970039 Netherlands ⤷  Try it Free PRODUCT NAME: [1R-[1 ALPHA (Z),2 BETA(R*),3 ALPHA,5ALPHA]]-7-[3,5-DIHYDROXY-2-(3-HYDROXY-5- FENYLPENTYL)CYCLOPENTYL]-5-HEPTEENZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN ESTER, IN HET BIJZONDER LATANOPROSTUM; NAT. REGISTRATION NO/DATE: RVG 21304 19970610; FIRST REGISTRATION: SE 12716 19960718
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
Mallinckrodt
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.